CClinicalTrials.gg
RecruitingNCT03979391OBITUpdated Sep 13, 2023

Isoelectric Focusing of Tears in Children With Radiologically Isolated or Clinically Isolated Syndrome

An interventional study of Tear collection and lumbar punction in Clinically Isolated Syndrome, Radiologically Isolated Syndrome and Multiple Sclerosis in Children, sponsored by Lille Catholic University. Recruiting at 1 site in France. Open to participants aged Up to 18 Years. Per ClinicalTrials.gov, last updated 2023-09-13.

Sponsored by Lille Catholic University · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Primary completion was expected by Nov 2024, 1 year 10 months ago, but the record still lists the study as recruiting.
  • Started Sep 2019; still recruiting 7 years later.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
Up to 18 Years
Sex
All
01

Study summary

The main gold of this study is to lead a multicentric, prospective study, to evaluate the diagnostic quality of tears in children with clinically isolated syndrome (CIS) and radiologically isolated syndrome (RIS) during a longitudinal follow-up.

Read the detailed description

Multiple Sclerosis (MS) is a disease that affects the white matter of the central nervous system. In France, approximately 100,000 patients are affected. It is one of the most common neurological condition in young adults.

The presence of supernumerary oligoclonal bands (OCBs) in the cerebrospinal fluid (CSF) in comparison to the serum was established in 2017 as a criterion for temporal dissemination in MS patients. This is a predictive factor of conversion to MS in the clinically isolated syndrome (CIS) and radiologically isolated syndrome (RIS), either in children or adults.

However, the main inconvenient of OCB analysis in CSF is the requirement of a lumbar puncture, which is a traumatising technique that may raise ethical concerns especially when it has to be performed in children.

Searching for OCBs in tears, which are more accessible, may represent an attractive alternative. Some published articles studying adult populations go in this direction, but there are no data in the literature regarding children.

The main gold of this study is to lead a multicentric, prospective study, to evaluate the diagnostic quality of tears in children with clinically isolated syndrome (CIS) and radiologically isolated syndrome (RIS) during a longitudinal follow-up.

02

Conditions studied

  • Clinically Isolated Syndrome
  • Radiologically Isolated Syndrome
  • Multiple Sclerosis in Children

Keywords

  • Clinically Isolated Syndrome
  • Radiologically Isolated Syndrome
  • Multiple Sclerosis
  • Children
  • Tear analysis
03

In context

Multiple Sclerosis

3,460 studies on the registry are indexed under Multiple Sclerosis; 661 are open to participants now.

This study's planned enrollment of 20 is below the median of 50 across 2,342 interventional studies indexed under Multiple Sclerosis.

Browse Multiple Sclerosis studies →

Lead sponsor

Lille Catholic University is the lead sponsor of 111 studies on the registry; 26 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • age \< 18 years old
  • informed consent from the child and the parents (at least one of the two legal guardians)
  • child covered by social security

For the RIS population:

  • asymptomatic child
  • fortuitous discovery of lesions strongly suggesting sclerosis multiple on a Magnetic resonance imaging (MRI) scan

For the CIS population:

  • child presenting a CIS in the past three months

Exclusion criteria

Exclusion Criteria:

  • patient with remitting MS
  • patient with progressive MS
  • patient with eye infection
  • patient under immunosuppressive therapy on the day of inclusion due to the treatment of another disease than MS
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Children with CIS or RIS

    The detection of supernumerary oligoclonal bands (OCBs) in tears will be performed

    Diagnostic Test: Tear collection and lumbar punction

Interventions

  • Diagnostic testTear collection and lumbar punction

    Tear collection and lumbar punction will be performed in order to detect supernumerary oligoclonal bands

06

What researchers measure

Primary outcomes

  1. Sensitivity of tears analysis compared to lumbar punction analysis for the diagnosis of CIS and RIS

    To evaluate the diagnostic performance of tears analysis in children with CIS and RIS, (sensitivity, specificity, positive and negative predictive value) being the gold standard the cerebrospinal analysis

    Time frame: Day 0

  2. Specificity of tears analysis compared to lumbar punction analysis for the diagnosis of CIS and RIS

    To evaluate the diagnostic performance of tears analysis in children with CIS and RIS, (sensitivity, specificity, positive and negative predictive value) being the gold standard the cerebrospinal analysis

    Time frame: Day 0

  3. Positive predictive value of tears analysis compared to lumbar punction analysis for the diagnosis of CIS and RIS

    To evaluate the diagnostic performance of tears analysis in children with CIS and RIS, (sensitivity, specificity, positive and negative predictive value) being the gold standard the cerebrospinal analysis

    Time frame: Day 0

  4. Negative predictive value of tears analysis compared to lumbar punction analysis for the diagnosis of CIS and RIS

    To evaluate the diagnostic performance of tears analysis in children with CIS and RIS, (sensitivity, specificity, positive and negative predictive value) being the gold standard the cerebrospinal analysis

    Time frame: Day 0

Secondary outcomes

  1. Proportion of patients with OCBs in tears

    Time frame: day 0, one year

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 13, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03979391
Lead sponsor
Lille Catholic University
Responsible party
Sponsor
First posted
Jun 7, 2019
Start date
Sep 26, 2019
Primary completion
Nov 26, 2024 (estimated)
Completion
Nov 26, 2024 (estimated)
Last update
Sep 13, 2023

Study contacts

Lebitasy Marie Paule, PhD
Contact
Lebitasy.Marie-Paule@ghicl.net
03.20.22.57.41
Hautecoeur Patrick
principal investigator · Lille Catholic University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion